Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$112M |
| 2 |
Ferguson
FERG
|
+$104M |
| 3 |
Amazon
AMZN
|
+$101M |
| 4 |
Apple
AAPL
|
+$98.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$75M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$52.5M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$38.1M |
| 5 |
Equity Residential
EQR
|
+$22.8M |
Sector Composition
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Communication Services | 10.9% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Five Point Holdings
FPH
$417M
| $890K | ﹤0.01% |
117,700
| – | – |
|
2377
Ardelyx
ARDX
$1.58B
| $888K | ﹤0.01% |
134,100
+5,100
| +4% | +$33.8K |
|
|
AGEN
2378
Agenus
AGEN
$162M
| $886K | ﹤0.01% |
16,605
+754
| +5% | +$40.2K |
|
2379
Dorian LPG
LPG
$1.34B
| $873K | ﹤0.01% |
66,485
-20,015
| -23% | -$263K |
|
2380
Future Fuel
FF
$169M
| $870K | ﹤0.01% |
59,909
| – | – |
|
|
MGIC
2381
Magic Software Enterprises
MGIC
$982M
| $867K | ﹤0.01% |
55,780
| – | – |
|
2382
Precision BioSciences
DTIL
$60M
| $857K | ﹤0.01% |
2,760
| – | – |
|
2383
Alto Ingredients
ALTO
$89.8M
| $852K | ﹤0.01% |
156,900
+20,500
| +15% | +$111K |
|
2384
Tejon Ranch
TRC
$447M
| $847K | ﹤0.01% |
50,580
| – | – |
|
2385
Annexon
ANNX
$233M
| $841K | ﹤0.01% |
30,200
| – | – |
|
2386
UroGen Pharma
URGN
$957M
| $828K | ﹤0.01% |
42,500
| – | – |
|
|
OLP
2387
One Liberty Properties
OLP
$497M
| $827K | ﹤0.01% |
37,152
| – | – |
|
2388
Merchants Bancorp
MBIN
$1.46B
| $826K | ﹤0.01% |
29,550
| – | – |
|
2389
McEwen Inc.
MUX
$734M
| $826K | ﹤0.01% |
79,403
+2,270
| +3% | +$23.6K |
|
2390
Viemed Healthcare
VMD
$260M
| $822K | ﹤0.01% |
80,900
+3,000
| +4% | +$30.5K |
|
2391
Neurogene
NGNE
$275M
| $814K | ﹤0.01% |
3,305
| – | – |
|
2392
VirnetX
VHC
$76.3M
| $814K | ﹤0.01% |
7,305
+190
| +3% | +$21.2K |
|
2393
ANI Pharmaceuticals
ANIP
$2.14B
| $810K | ﹤0.01% |
22,400
| – | – |
|
2394
KRONOS Worldwide
KRO
$724M
| $808K | ﹤0.01% |
52,800
| – | – |
|
2395
Stoke Therapeutics
STOK
$1.21B
| $800K | ﹤0.01% |
20,600
+1,800
| +10% | +$69.9K |
|
2396
RAPT Therapeutics
RAPT
$225M
| $799K | ﹤0.01% |
4,500
| – | – |
|
2397
Duluth Holdings
DLTH
$124M
| $789K | ﹤0.01% |
46,600
| – | – |
|
|
STFC
2398
DELISTED
State Auto Financial Corp
STFC
| $784K | ﹤0.01% |
39,800
| – | – |
|
2399
Vital Farms
VITL
$2.12B
| $780K | ﹤0.01% |
35,700
| – | – |
|
2400
Cadiz
CDZI
$285M
| $779K | ﹤0.01% |
81,200
+3,600
| +5% | +$34.5K |
|